These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35811515)

  • 1. Frontal Atrophy and Executive Dysfunction Relate to Complex Numbers Impairment in Progressive Supranuclear Palsy.
    Howard E; Ballinger S; Kinney NG; Balgenorth Y; Ehrhardt A; Phillips JS; Irwin DJ; Grossman M; Cousins KAQ
    J Alzheimers Dis; 2022; 88(4):1553-1566. PubMed ID: 35811515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phonemic Verbal Fluency and Midbrain Atrophy in Progressive Supranuclear Palsy.
    Luca A; Nicoletti A; Donzuso G; Terravecchia C; Cicero CE; D'Agate C; Rascuná C; Manna R; Mostile G; Zappia M
    J Alzheimers Dis; 2021; 80(4):1669-1674. PubMed ID: 33720901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodic memory in progressive supranuclear palsy: a neuropsychological and neuroimaging study.
    Macedo AC; Caramelli P; de Paula França Resende E; Mariano LI; Tumas V; Teixeira AL; Camargos ST; Cardoso FEC; de Souza LC
    Neurol Sci; 2022 Sep; 43(9):5363-5368. PubMed ID: 35633422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visuospatial functions in atypical parkinsonian syndromes.
    Bak TH; Caine D; Hearn VC; Hodges JR
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):454-6. PubMed ID: 16543521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathomechanisms of cognitive impairment in progressive supranuclear palsy.
    Jellinger KA
    J Neural Transm (Vienna); 2023 Apr; 130(4):481-493. PubMed ID: 36862189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunction and impaired organization of complex motility in degenerative parkinsonian syndromes.
    Monza D; Soliveri P; Radice D; Fetoni V; Testa D; Caffarra P; Caraceni T; Girotti F
    Arch Neurol; 1998 Mar; 55(3):372-8. PubMed ID: 9520011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
    Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Frontal Assessment Battery in detection of neuropsychological dysfunction in Richardson variant of progressive supranuclear palsy.
    Sitek EJ; Konkel A; Dąbrowska M; Sławek J
    Neurol Neurochir Pol; 2015; 49(1):36-40. PubMed ID: 25666771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I'm looking through you: Mentalizing in frontotemporal dementia and progressive supranuclear palsy.
    de Souza LC; Bertoux M; Radakovic R; Hornberger M; Mariano LI; Resende EPF; Quesque F; Guimarães HC; Gambogi LB; Tumas V; Camargos ST; Cardoso FEC; Teixeira AL; Caramelli P
    Cortex; 2022 Oct; 155():373-389. PubMed ID: 36116296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Progressive Supranuclear Palsy: Past and Present Aspects.
    Parthimos TP; Schulpis KH
    Clin Gerontol; 2020; 43(2):155-180. PubMed ID: 31752626
    [No Abstract]   [Full Text] [Related]  

  • 20. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing.
    Paviour DC; Winterburn D; Simmonds S; Burgess G; Wilkinson L; Fox NC; Lees AJ; Jahanshahi M
    Neurocase; 2005 Aug; 11(4):274-82. PubMed ID: 16093228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.